Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 EUR | -.--% | -.--% | -.--% |
Feb. 23 | Praemia Healthcare Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Praemia Healthcare Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | 298M 319M | Sales 2022 | 355M 380M | Capitalization | 5.54B 5.94B |
---|---|---|---|---|---|
Net income 2021 | 491M 526M | Net income 2022 | 378M 405M | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Xavier Cheval
CEO | Chief Executive Officer | 41 | 10-12-31 |
Helga Camalon
DFI | Director of Finance/CFO | - | 23-06-30 |
Marc Nguyen Dinh
CIO | Chief Investment Officer | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jérôme Lucchini
BRD | Director/Board Member | 57 | 13-12-31 |
Director/Board Member | 68 | 21-09-20 | |
Victoire Aubry
BRD | Director/Board Member | 57 | 21-09-20 |
- Stock Market
- Equities
- IS Stock